These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30483553)

  • 1. Mesenchymal stem cell therapy for advanced liver cirrhosis: A case report.
    Rajaram R; Subramani B; Abdullah BJJ; Mahadeva S
    JGH Open; 2017 Dec; 1(4):153-155. PubMed ID: 30483553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Bagheri M; Ashrafi M; Abdollahzadeh L; Akhlaghpoor S; Bashtar M; Ghavamzadeh A; Malekzadeh R
    Liver Int; 2013 Nov; 33(10):1490-6. PubMed ID: 23763455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial.
    Suk KT; Yoon JH; Kim MY; Kim CW; Kim JK; Park H; Hwang SG; Kim DJ; Lee BS; Lee SH; Kim HS; Jang JY; Lee CH; Kim BS; Jang YO; Cho MY; Jung ES; Kim YM; Bae SH; Baik SK
    Hepatology; 2016 Dec; 64(6):2185-2197. PubMed ID: 27339398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease.
    Salama H; Zekri AR; Medhat E; Al Alim SA; Ahmed OS; Bahnassy AA; Lotfy MM; Ahmed R; Musa S
    Stem Cell Res Ther; 2014 May; 5(3):70. PubMed ID: 24886681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.
    Zhang Z; Lin H; Shi M; Xu R; Fu J; Lv J; Chen L; Lv S; Li Y; Yu S; Geng H; Jin L; Lau GK; Wang FS
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():112-20. PubMed ID: 22320928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study.
    Jang YO; Kim YJ; Baik SK; Kim MY; Eom YW; Cho MY; Park HJ; Park SY; Kim BR; Kim JW; Soo Kim H; Kwon SO; Choi EH; Kim YM
    Liver Int; 2014 Jan; 34(1):33-41. PubMed ID: 23782511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.
    Sharma M; Rao PN; Sasikala M; Kuncharam MR; Reddy C; Gokak V; Raju B; Singh JR; Nag P; Nageshwar Reddy D
    World J Gastroenterol; 2015 Jun; 21(23):7264-71. PubMed ID: 26109814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can bone marrow-derived mesenchymal stem cells change liver volume?: A case report.
    Kim K; Shin IS; Bang HJ; An S; Ha G; Kim HS; Bae KS
    JGH Open; 2021 Feb; 5(2):320-323. PubMed ID: 33553676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.
    Zekri AR; Salama H; Medhat E; Musa S; Abdel-Haleem H; Ahmed OS; Khedr HA; Lotfy MM; Zachariah KS; Bahnassy AA
    Stem Cell Res Ther; 2015 Jun; 6(1):118. PubMed ID: 26062731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases.
    Liang J; Zhang H; Zhao C; Wang D; Ma X; Zhao S; Wang S; Niu L; Sun L
    Int J Rheum Dis; 2017 Sep; 20(9):1219-1226. PubMed ID: 28217916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Mohyeddin-Bonab M; Bagheri M; Bashtar M; Ghanaati H; Baharvand H; Ghavamzadeh A; Malekzadeh R
    Arch Iran Med; 2007 Oct; 10(4):459-66. PubMed ID: 17903050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Assessment of Autologous Stem Cell Combination Therapy in Patients With Decompensated Liver Cirrhosis: A Pilot Study.
    Sharma M; Pondugala PK; Jaggaihgari S; Mitnala S; Krishna VV; Jaishetwar G; Naik P; Kumar P; Kulkarni A; Gupta R; Singh JR; Darisetty S; Sekharan A; Reddy DN; Rao GV; Syeda F; Jagtap N; Rao PN
    J Clin Exp Hepatol; 2022; 12(1):80-88. PubMed ID: 35068788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial.
    Shi M; Li YY; Xu RN; Meng FP; Yu SJ; Fu JL; Hu JH; Li JX; Wang LF; Jin L; Wang FS
    Hepatol Int; 2021 Dec; 15(6):1431-1441. PubMed ID: 34843069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis.
    Pan XN; Zheng LQ; Lai XH
    World J Gastroenterol; 2014 Oct; 20(38):14051-7. PubMed ID: 25320545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis.
    Nikeghbalian S; Pournasr B; Aghdami N; Rasekhi A; Geramizadeh B; Hosseini Asl SM; Ramzi M; Kakaei F; Namiri M; Malekzadeh R; Vosough Dizaj A; Malek-Hosseini SA; Baharvand H
    Arch Iran Med; 2011 Jan; 14(1):12-7. PubMed ID: 21194255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Autologous Bone Marrow Stem Cell Therapy in Patients with Liver Cirrhosis: A Meta-analysis.
    Wu CX; Wang D; Cai Y; Luo AR; Sun H
    J Clin Transl Hepatol; 2019 Sep; 7(3):238-248. PubMed ID: 31608216
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.
    Kim JK; Kim SJ; Kim Y; Chung YE; Park YN; Kim HO; Kim JS; Park MS; Sakaida I; Kim DY; Lee JI; Ahn SH; Lee KS; Han KH
    Cell Transplant; 2017 Jun; 26(6):1059-1066. PubMed ID: 28120743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.
    Salama H; Zekri AR; Zern M; Bahnassy A; Loutfy S; Shalaby S; Vigen C; Burke W; Mostafa M; Medhat E; Alfi O; Huttinger E
    Cell Transplant; 2010; 19(11):1475-86. PubMed ID: 20587151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study.
    Huang M; Feng Z; Ji D; Cao Y; Shi X; Chen P; Wang P; Tang M; Liu K
    Cytotherapy; 2014 Nov; 16(11):1575-1583. PubMed ID: 25287603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    Detry O; Vandermeulen M; Delbouille MH; Somja J; Bletard N; Briquet A; Lechanteur C; Giet O; Baudoux E; Hannon M; Baron F; Beguin Y
    J Hepatol; 2017 Jul; 67(1):47-55. PubMed ID: 28284916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.